Latest Insights on ADGI
This New Strategy Makes Sense of Biotechs’ Erratic MovesI find one type of stock equal parts frustrating and fascinating — biotechs.
EV Makers Finally Found a Supply Chain SolutionAutomakers lost control over their supply chains. And they aren’t looking to repeat this mistake with their EV projects.
BIG Market Moves Mean BIG OpportunitiesWhen the market moves this much, day trading has the potential to be lucrative.
A Stock-Picking Mutation to Beat the Omicron ThreatThis is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.